| Literature DB >> 7901684 |
H H Mahmoud1, C A Hurwitz, W M Roberts, V M Santana, R C Ribeiro, R A Krance.
Abstract
Tretinoin is effective in acute promyelocytic leukaemia in adults. Data about its efficacy and safety in children are limited. We have treated 9 children with tretinoin at 45 mg/m2 per day. Pseudotumour cerebri or hyperleucocytosis occurred in 5 patients. Retinoic acid syndrome was seen in 3 cases. 1 of 2 children who developed hyperleucocytosis, pseudotumour cerebri, and retinoic acid syndrome died despite steroids and mechanical ventilation. Complete remissions with tretinoin alone were achieved in 15 patients. All 8 surviving children received consolidation chemotherapy. Our experience with tretinoin therapy suggests that toxicity is frequent in children.Entities:
Mesh:
Substances:
Year: 1993 PMID: 7901684 DOI: 10.1016/0140-6736(93)92755-i
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321